WallStreetZenWallStreetZen

NASDAQ: CCCC
C4 Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CCCC

Based on 3 analysts offering 12 month price targets for C4 Therapeutics Inc.
Min Forecast
$3.00+61.29%
Avg Forecast
$10.00+437.63%
Max Forecast
$17.00+813.98%

Should I buy or sell CCCC stock?

Based on 3 analysts offering ratings for C4 Therapeutics Inc.
Hold
Strong Buy
0 analysts 0%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 33.33%

Be the first to know when Wall Street analysts revise their CCCC stock forecasts and price targets.

CCCC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 1%
1
BuyMaintains$17.00+813.98%2023-08-09
Evercore ISI Group
Bottom 17%
17
BuyMaintains$10.00+437.63%2023-05-30
Morgan Stanley
Top 7%
94
Strong SellMaintains$3.00+61.29%2023-05-12

1 of 1

Forecast return on equity

Is CCCC forecast to generate an efficient return?
Company
N/A
Industry
0.63%
Market
28.75%

Forecast return on assets

Is CCCC forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.08%

CCCC revenue growth forecast

How is CCCC forecast to perform vs Biotechnology companies and vs the US market?
Company
39.91%
Industry
34.89%
Market
8.15%
CCCC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CCCC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CCCC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CCCC$1.86$10.00+437.63%Hold
SPRB$2.26$7.67+239.25%Buy
CARA$1.68$16.50+882.14%Buy
ACHV$4.30$19.00+341.86%Strong Buy
RLMD$3.00$26.00+766.67%Strong Buy
View Top Biotech Stocks

C4 Therapeutics Stock Forecast FAQ

Is C4 Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CCCC) stock is to Hold CCCC stock.

Out of 3 analysts, 0 (0%) are recommending CCCC as a Strong Buy, 2 (66.67%) are recommending CCCC as a Buy, 0 (0%) are recommending CCCC as a Hold, 0 (0%) are recommending CCCC as a Sell, and 1 (33.33%) are recommending CCCC as a Strong Sell.

If you're new to stock investing, here's how to buy C4 Therapeutics stock.

What is CCCC's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: CCCC) forecast ROE is N/A, which is considered weak.

What is CCCC's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CCCC price target, the average CCCC price target is $10.00, with the highest CCCC stock price forecast at $17.00 and the lowest CCCC stock price forecast at $3.00.

On average, Wall Street analysts predict that C4 Therapeutics's share price could reach $10.00 by Aug 9, 2024. The average C4 Therapeutics stock price prediction forecasts a potential upside of 437.63% from the current CCCC share price of $1.86.

What is CCCC's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: CCCC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.08%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.